Archive for December 2019
Permanent Hair Dye and Straighteners May Increase Breast Cancer Risk
Scientists at the National Institutes of Health found that women who use permanent hair dye and chemical hair straighteners have a higher risk of developing breast cancer than women who don’t use these products. The study published online Dec. 4 in the International Journal of Cancer and suggests that breast cancer risk increased with more…
Read MoreSiemens Healthineers Brings Head CT Scanner to the Patient Bedside
At RSNA 2019, Siemens Healthineers is presenting its new mobile head CT scanner, Somatom On.site1. Instead of patients having to be transferred to the radiology department for a CT scan, the new mobile system from Siemens Healthineers now allows the scanner to be taken to the ICU so that patients can be examined from their…
Read MoreALung Technologies Announces Continued Progress Towards Completion of Two Landmark Pivotal Trials
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced the recent achievement of two significant clinical trial milestones, enrollment of 60 plus patients in its U.S. based VENT-AVOID clinical trial and greater than 400 patients in the UK-REST clinical trial. COPD affects 30…
Read MoreFDA Has Cleared Two Intuitive Technologies for Use in Sealing Procedures
Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced U.S. Food and Drug Administration clearance of two innovative technologies for two of the company’s da Vinci® surgical systems to help improve procedures that require sealing. Intuitive’s E-100 generator is its first internally developed robotic generator to power two key…
Read MoreBaxter to Expand Advanced Surgery Portfolio With Acquisition of Seprafilm Adhesion Barrier
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today entered into a definitive agreement to acquire Seprafilm Adhesion Barrier and related assets from Sanofi. The agreement is the latest example of Baxter’s continued focus on acquiring products and technologies that have a strong strategic fit with the company’s leading portfolio across the hospital, including in…
Read MoreGenetron Health Obtains Approval for Semiconductor-based NGS System GENETRON S5
Genetron Health, a China-based precision oncology company that covers full-cycle cancer care, has obtained regulatory approval in China to launch its GENETRON S5 for clinical use. The approval of a new desktop medium-throughput semiconductor-based next generation sequencing (NGS) system—GENETRON S5, showcases Genetron Health’s ongoing commitment to providing early screening, diagnosis and treatment recommendations, as well…
Read More